semaglutide liraglutide tirzepatide The recommended dosing schedule for liraglutide, semaglutide, and Liraglutide or Tirzepatide? My Patients'

10.1111/j.1460-9568.2008.06099.x 68

Wegovy (semaglutide) is a GLP-1 receptor agonist that slows gastric emptying, potentially exacerbating pre-existing gastric conditions Common gastrointestinal side effects include nausea (44%), vomiting (24%), dyspepsia, abdominal pain, and constipation Gastritis is not listed as a recognised adverse effect in the UK Summary of Product Characteristics Patients with severe gastrointestinal disease or history of peptic ulcer disease should discuss risks with their prescriber before starting treatment Seek urgent medical advice for severe abdominal pain, vomiting blood, black stools, or persistent symptoms that do not improve Table of Contents Can Wegovy Cause Gastritis

Research use only (not for human or veterinary use) Get notified when it's back in stock Purity: 99% (HPLC) Batch-controlled manufacturing Secure packaging for laboratory handling Storage: Store lyophilised powder frozen for long-term stability

It risks: Weight regain and worsening of obesity-related comorbidities